Oulu-based Finnadvance has been recently selected for the Pitch 40 Competition organized by TechArena. This prestigious event brings together promising startups and innovative companies to showcase their groundbreaking technologies. Finnadvance’s inclusion highlights their impact on the biotech landscape.
TechArena, an international platform for innovation, entrepreneurship, and sustainability, brings together entrepreneurs, business leaders, experts, investors, decision-makers, and politicians. Their platform includes yearly tech events, a Nordic entrepreneurship competition, and tech-focused news.
The Road Ahead
As Finnadvance continues to refine its OOC technology, the pharmaceutical industry eagerly awaits its contributions. With better pre-clinical data, reduced costs, and more accurate biomimetic models, Finnadvance is poised to shape the future of drug development.
Finnadvance: Pioneering Organ-on-a-Chip Technology for Precise Drug Discovery
In the heart of Oulu, Finland, a groundbreaking company is making waves in pharmaceutical research and development. Finnadvance, founded in 2018, has emerged as a trailblazer in the field of organ-on-a-chip technology. Their innovative approach promises to revolutionize drug discovery, making it more precise, efficient, and humane.
Source: Finnadvance